Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1โ€“36
Headlines
258
Sources here
14
Companies here
5
Current section Germany Diagnostics & Research news
Latest

finance.yahoo.com Market update

QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel

Bloodstream infections can trigger sepsis, a life-threatening response to infection; about 1.7 million U.S. adults develop sepsis each year, contributing to at least 350,000 deaths New QIAstat-Dx test identifies 13 gram-negative bacterial targets and 18 antibiotic resistance markers in about one hour Complete QIAstat-Dx bloodstream infection menu combines two complementary panels and covers 33 pathogen targets and 28 โ€ฆ

Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany
Read at finance.yahoo.com
Sharemaestro market context Trend signal active 52 weeks -1.3% ยท Next-week setup negative 43.2% QIA stored weekly price path from 3 Oct 2025 to 25 Sep 2026
Just inNext headlines
Zacks Market update Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. Another factor that can influence investors is FOMO, or the fear of โ€ฆ

TN8 main company
Sharemaestro market context Trend signal active 52 weeks +29.9% TN8 stored weekly price path from 3 Oct 2025 to 25 Sep 2026

Chronological news

Latest headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

MT Newswires Market update Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation

Compact system offers research laboratories a time-saving and cost-efficient way to automate work still done by hand Reduction in hands-on time of over 80% compared with manual sample processing Third new sample preparation system launched in 2026 expands automation portfolio from small research labs โ€ฆ

QIA main company
Sharemaestro market context Trend signal active 52 weeks -1.3% ยท Next-week setup negative 43.2% QIA stored weekly price path from 3 Oct 2025 to 25 Sep 2026
Zacks Market update Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now

QIAGEN N.V. QGEN is well positioned for growth in the upcoming quarters, supported by continued test menu expansion. Meanwhile, strategic partnerships support assay development and create opportunities for recurring consumables revenues across clinical, research and biopharma markets. However, cautious customer spending, weaker research funding โ€ฆ

QIA main company
Sharemaestro market context Trend signal active 52 weeks -1.3% ยท Next-week setup negative 43.2% QIA stored weekly price path from 3 Oct 2025 to 25 Sep 2026
Simply Wall St. Market update Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Thermo Fisher Scientific (TMO) Launches Gibco CHO K1 Panel On A Fair Value Question

Thermo Fisher Scientific (TMO) has introduced the Gibco CHO-K1 Catalog Panel, a cGMP-ready media portfolio aimed at improving cell growth, protein yield, and workflow flexibility for biologics and biosimilars developers. Thermo Fisher Scientific sits at US$665.30 per share after a 30-day share price return โ€ฆ

TN8 main company
Sharemaestro market context Trend signal active 52 weeks +29.9% TN8 stored weekly price path from 3 Oct 2025 to 25 Sep 2026
Business Wire Market update Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Eurofins Scientific: Director/PDMR Shareholding

LUXEMBOURG, September 21, 2026--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. โ€ฆ

ESF0 main company
Sharemaestro market context Trend signal active 52 weeks +26.0% ESF0 stored weekly price path from 3 Oct 2025 to 25 Sep 2026
Simply Wall St. Market update Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Thermo Fisher Scientific (TMO) Rolls Out New Media Panel For Biologics Development

Thermo Fisher Scientific (NYSE:TMO) has introduced the Gibco CHO-K1 Catalog Panel, a new off the shelf media offering for biologics developers. The panel includes cGMP ready, chemically defined, animal origin free basal and feed media aimed at broad process development and manufacturing use. The โ€ฆ

TN8 main company
Sharemaestro market context Trend signal active 52 weeks +29.9% TN8 stored weekly price path from 3 Oct 2025 to 25 Sep 2026
Simply Wall St. Balance sheet Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Danaher (DHR) Stock Looks Reasonable On Label Free Detection Growth

Danaher has delivered a 17.4% gain over the past year, which puts a spotlight on one core issue for anyone looking at the stock today: whether the current share price can be explained by the cash flows the business is expected to generate. The โ€ฆ

DAP main company
Sharemaestro market context Trend signal active 52 weeks +7.1% ยท Next-week setup negative 44.0% DAP stored weekly price path from 3 Oct 2025 to 25 Sep 2026
Business Wire Market update Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Thermo Fisher Scientific Launches Gibcoโ„ข CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development

New cGMP-ready media and feed panel helps developers rapidly identify high-performing combinations, with study results demonstrating up to 73% higher titer versus benchmark catalog media and feeds and up to 202% higher peak viable cell density compared with benchmark products tested Key facts Product: โ€ฆ

TN8 main company
Sharemaestro market context Trend signal active 52 weeks +29.9% TN8 stored weekly price path from 3 Oct 2025 to 25 Sep 2026
PR Newswire Earnings Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Danaher Schedules Third Quarter 2026 Earnings Conference Call

WASHINGTON, Sept. 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2026 on Wednesday, October 21, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the โ€ฆ

DAP main company
Sharemaestro market context Trend signal active 52 weeks +7.1% ยท Next-week setup negative 44.0% DAP stored weekly price path from 3 Oct 2025 to 25 Sep 2026
GlobeNewswire Earnings Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Capitalize on the Label-Free Detection Market Shift: Track How Danaher, Sartorius, Agilent, Bruker and Revvity Are Disrupting R&D ROI and Reshaping Global Revenue Through 2030

Company Logo AI-enabled, microfluidic label-free detection is expanding in drug discovery, early diagnostics, food safety and environmental testing, driven by efficient, non-invasive, sustainable workflows. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Label-Free Detection - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. โ€ฆ

DAP main company
Sharemaestro market context Trend signal active 52 weeks +7.1% ยท Next-week setup negative 44.0% DAP stored weekly price path from 3 Oct 2025 to 25 Sep 2026
GlobeNewswire Earnings Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Capitalize on High Content Screening Disruption: Decode How Thermo Fisher Scientific, Danaher, Revvity, and Yokogawa Are Reshaping Global R&D ROI and Revenue

Company Logo High-content screening is advancing drug discovery and personalized medicine, driven by 3D models, advanced imaging and automated analytics, with opportunities in cancer research and organoids. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "High Content Screening (HCS) - Global Strategic Business Report" has โ€ฆ

TN8 main company
Sharemaestro market context Trend signal active 52 weeks +29.9% TN8 stored weekly price path from 3 Oct 2025 to 25 Sep 2026
GlobeNewswire Market update Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Capitalize on the High Throughput Screening Shift: Track Thermo Fisher, Agilent, Danaher, Revvity and Tecan as AI-Driven Drug Discovery Reshapes R&D ROI

Company Logo AI, automation, robotics, microfluidics and nanotechnology are advancing HTS, while personalized medicine, biologics, research funding and pharma-academia partnerships drive demand. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "High Throughput Screening (HTS) - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. โ€ฆ

TN8 main company
Sharemaestro market context Trend signal active 52 weeks +29.9% TN8 stored weekly price path from 3 Oct 2025 to 25 Sep 2026
Business Wire Capital return Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Eurofins Scientific SE: Director/PDMR Shareholding

LUXEMBOURG, September 21, 2026--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. โ€ฆ

ESF0 main company
Sharemaestro market context Trend signal active 52 weeks +26.0% ESF0 stored weekly price path from 3 Oct 2025 to 25 Sep 2026
Business Wire Regulatory and legal Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Eurofins: Weekly Report on Share Repurchases From 14th September to 18th September 2026

LUXEMBOURG, September 21, 2026--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS โ€ฆ

ESF0 main company
Sharemaestro market context Trend signal active 52 weeks +26.0% ESF0 stored weekly price path from 3 Oct 2025 to 25 Sep 2026
finance.yahoo.com Market update Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets

Key Points Interested in IDEXX Laboratories, Inc.? Here are five stocks we like better. IDEXX reaffirmed its long-term growth targets of more than 10% organic revenue growth and more than 15% EPS growth, supported by recurring-revenue momentum and a large, underpenetrated veterinary diagnostics market. โ€ฆ

IX1 main company
Sharemaestro market context Price below Trend Line 51 weeks +14.4% ยท Next-week setup negative 30.8% IX1 stored weekly price path from 19 Sep 2025 to 25 Sep 2026
finance.yahoo.com Earnings Provider-linked mention ๐Ÿ‡ฉ๐Ÿ‡ช Germany

IDEXX (IDXX) Bets an AI Scribe Can Sell More Pet Diagnostics

On September 16, IDEXX Laboratories (NASDAQ:IDXX) announced it had bought CoVetAI, a fast-growing veterinary software company whose tool listens during appointments and organizes what gets said and done. It sounds like a productivity gadget. But IDEXX is pitching it as a way to put โ€ฆ

IX1 mentioned
Sharemaestro market context Price below Trend Line 51 weeks +14.4% ยท Next-week setup negative 30.8% IX1 stored weekly price path from 19 Sep 2025 to 25 Sep 2026
Business Wire Regulatory and legal Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board

VENLO, Netherlands, September 18, 2026--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it will hold an Extraordinary General Meeting of Shareholders on November 6, 2026, at 2:00 p.m. CET. Shareholders will be asked to vote on the appointment of Jonathan โ€ฆ

QIA main company
Sharemaestro market context Trend signal active 52 weeks -1.3% ยท Next-week setup negative 43.2% QIA stored weekly price path from 3 Oct 2025 to 25 Sep 2026
Insider Monkey Market update Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Thermo Fisher Scientific (TMO) is Positioned for Resurgence

Fenimore Asset Management, an investment management company, released its Q2 2026 investor letter. You can download the letter here. U.S. equity markets saw broad gains in Q2, driven by strong corporate earnings, economic resilience, and enthusiasm for artificial intelligence (AI). Major indices reached all-time โ€ฆ

TN8 main company
Sharemaestro market context Trend signal active 52 weeks +29.9% TN8 stored weekly price path from 3 Oct 2025 to 25 Sep 2026
finance.yahoo.com Deals and strategy Provider-linked mention ๐Ÿ‡ฉ๐Ÿ‡ช Germany

IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide

IDEXX Laboratories has seen a mixed share price story in recent years, and the question now is whether its current US$506.48 level lines up with the cash flows the business may generate over time. Recent price pressure and fresh AI-driven software ambitions are pulling โ€ฆ

IX1 mentioned
Sharemaestro market context Price below Trend Line 51 weeks +14.4% ยท Next-week setup negative 30.8% IX1 stored weekly price path from 19 Sep 2025 to 25 Sep 2026
finance.yahoo.com Deals and strategy Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

IDEXX Laboratories (IDXX) Could Be 29% Below Fair Value As Diagnostics Growth Stays In Focus

IDEXX Laboratories (IDXX) drew fresh attention after expanding its Faecal Dx antigen testing platform in the United Kingdom to cover taeniid tapeworms, including Taenia and Echinococcus species, during routine veterinary visits. Recent moves by IDEXX Laboratories, including the Faecal Dx expansion and the CoVetAI โ€ฆ

IX1 main company
Sharemaestro market context Price below Trend Line 51 weeks +14.4% ยท Next-week setup negative 30.8% IX1 stored weekly price path from 19 Sep 2025 to 25 Sep 2026
TIKR Analyst action Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Three Analysts, Three Verdicts on Thermo Fisher: Hereโ€™s Who the Numbers Favor

Three Analysts, Three Verdicts on Thermo Fisher: Here's Who the Numbers Favor ยฉTIKR Key Stats for Thermo Fisher Stock Current Price: $641.39 Target Price (Mid): ~$839 Street Target: ~$645 Potential Total Return: ~31% Annualized IRR: ~7% / year What Happened? Thermo Fisher Scientific (TMO) โ€ฆ

TN8 main company
Sharemaestro market context Trend signal active 52 weeks +29.9% TN8 stored weekly price path from 3 Oct 2025 to 25 Sep 2026
Simply Wall St. Market update Main company ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Why Is Thermo Fisher Scientific (TMO) Building A Massive Early Disease Data Platform?

Thermo Fisher Scientific (NYSE:TMO) and Mayo Clinic announced the formation of Precure, LLC for early disease detection using multi omic data. Precure plans to integrate proteomic, genomic, and longitudinal clinical records into a single biomedical dataset to identify early disease signals. The collaboration positions โ€ฆ

TN8 main company
Sharemaestro market context Trend signal active 52 weeks +29.9% TN8 stored weekly price path from 3 Oct 2025 to 25 Sep 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context